Modest Improvements in Refractory Antibody-Mediated Rejection After Prolonged Treatment
Kidney Int Rep
.
2021 Feb 23;6(5):1397-1401.
doi: 10.1016/j.ekir.2021.02.033.
eCollection 2021 May.
Authors
Kenna R Degner
1
,
Sandesh Parajuli
2
,
Fahad Aziz
2
,
Neetika Garg
2
,
Maha Mohamed
2
,
Didier A Mandelbrot
2
,
Sarah E Panzer
2
,
Nancy A Wilson
1
2
,
Shannon R Reese
2
,
Kristin Van Hyfte
3
,
Weixiong Zhong
4
,
Luis G Hidalgo
1
,
Peter Nickerson
5
,
Arjang Djamali
1
2
Affiliations
1
Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
2
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
3
The Office of Clinical Trials, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
4
Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
5
Department of Internal Medicine and Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
PMID:
34013117
PMCID:
PMC8116765
DOI:
10.1016/j.ekir.2021.02.033
No abstract available
Keywords:
DSA; cABMR; histopathology; refractory; renal transplantation.
Grants and funding
K23 DK122136/DK/NIDDK NIH HHS/United States
T32 AI125231/AI/NIAID NIH HHS/United States